Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

Researchers from academia, government, and industry discuss how increasingly large, complex datasets can be harnessed to improve the drug development process.

M-CERSI’s “America’s Got Regulatory Science Talent” judges award student first prize for new technology to combat worldwide counterfeit drug crisis.

New part-time, online graduate program designed for working professionals focuses on drug product development and regulation.

Forum brings together FDA scientists, the University of Maryland community, and members of the public to discuss current issues in regulatory science and ongoing M-CERSI research, training, and exchange activities.

New developments in pharmaceutical manufacturing and topical drug bioequivalence and bioavailability addressed in two day-long workshops.

“America’s Got Regulatory Science Talent” judges award student first prize for his guidelines to improve reporting of adverse medication events to the Food and Drug Administration.

Center of Excellence in Regulatory Science and Innovation taps researchers at Baltimore and College Park campuses, Food and Drug Administration, and industry to make a difference.